Therapeutic Asset Ratings

6,308 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
DEXAMETHASONE Reproductive System Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
Diazepam Antibody Mediated Epilepsy	Mayo Clinic	P1/2	CCC (48)
DIPHENHYDRAMINE Oropharyngeal Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
DIPHENHYDRAMINE Reproductive System Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
DIPHTHERIA TOXOID Alzheimer Disease	Mindful Diagnostics and Therapeutics, LLC	P1/2	CCC (48)
DNA (recombinant adeno-associated virus vector AAV-Spark100-GAA human liver-specific expression cassette including human lysosomal ?-glucosidase codon-optimized gene GAA plus adeno-associated virus 2 inverted terminal repeat flanks) Lysosomal Storage Disease	Spark Therapeutics, Inc.	P1/2	CCC (48)
dnl126 Mucopolysaccharidosis Type 3A	Denali Therapeutics Inc.	P1/2	CCC (48)
doc1021 Melanoma	Diakonos Oncology Corporation	P1/2	CCC (48)
Docetaxel Esophageal Squamous Cell Carcinoma	Hummingbird Bioscience	P1/2	CCC (48)
Docetaxel Laryngeal Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Docetaxel Hypopharyngeal Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Docetaxel Head And Neck Carcinoma	OncoC4, Inc.	P1/2	CCC (48)
Docetaxel Nasopharyngeal Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Docetaxel Oral Cavity Squamous Cell Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Docetaxel Oropharynx Squamous Cell Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Docetaxel Paranasal Sinus Neoplasm	National Cancer Institute (NCI)	P1/2	CCC (48)
Domvanalimab Pancreatic Adenocarcinoma	James Cleary, MD, PhD	P1/2	CCC (48)
Domvanalimab Pancreatic Adenosquamous Carcinoma	James Cleary, MD, PhD	P1/2	CCC (48)
Domvanalimab Squamous Cell Carcinoma Of Pancreas	James Cleary, MD, PhD	P1/2	CCC (48)
Donor-Derived Ex-Vivo Expanded Ebv Tscm Ctl Epstein-Barr Virus-Associated Lymphoproliferative Disorder	University Hospital, Basel, Switzerland	P1/2	CCC (48)
Donor-Derived Ex-Vivo Expanded Ebv Tscm Ctl Post-Transplant Lymphoproliferative Disease	University Hospital, Basel, Switzerland	P1/2	CCC (48)
Dostarlimab Diffuse Intrinsic Pontine Glioma	GlaxoSmithKline	P1/2	CCC (48)
Dostarlimab Glioblastoma	GlaxoSmithKline	P1/2	CCC (48)
Dostarlimab Liver And Intrahepatic Bile Duct Neoplasm	GlaxoSmithKline	P1/2	CCC (48)
Dostarlimab Glioma	GlaxoSmithKline	P1/2	CCC (48)

Showing 1076 to 1100 of 6,308 assets

PreviousPage 44 of 253Next